Copay help by condition · Cancer and blood cancer · read 2026-11-08
Acute Myeloid Leukemia (AML): which charitable copay funds are open
2 funds for Acute Myeloid Leukemia say it is open right now, of the 4 we hold (read 2026-11-08).
Open: Acute Myeloid Leukemia from Blood Cancer United (formerly the Leukemia and Lymphoma Society) and Acute myeloid leukemia (AML) from TotalAssist (Patient Advocate Foundation copay funds). Eligibility is each fund's own rule.
If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.
Swipe to read across
A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.
Every fund we hold for Acute Myeloid Leukemia
- OpenAcute Myeloid Leukemia
Blood Cancer United (formerly the Leukemia and Lymphoma Society) ·
Award level: $4,000Insurance supported: Medicaid, Medicare, Private, TRICARE
The page lists the fund as Open. Source page
- OpenAcute myeloid leukemia (AML)
TotalAssist (Patient Advocate Foundation copay funds) ·
Award level: $8,600Insurance supported: Medicaid, Medicare, TRICARE
The page lists the fund as Open. Source page
- Closed or at capacityAcute Myeloid Leukemia
CancerCare ·
Award level: not statedInsurance supported: not stated
The page marks the fund as not currently open for new enrollments (the fund row's own data-statuses attribute reads closed). Source page
- Closed or at capacityAcute Myeloid Leukemia
HealthWell Foundation ·
Award level: not statedInsurance supported: not stated
The page lists the fund as Closed. Source page
Drugs whose FDA label names Acute Myeloid Leukemia
5 drugs. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 3 have a program (in our assistance finder or on the program's own page) and 0 have a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Idhifa Enasidenib Mesylate Every route for this drug | IDHIFA is an isocitrate dehydrogenase-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test ( 1. Label on openFDA, read 2026-11-10 | Bristol Myers Squibb Patient Assistance Foundation (program page) | not in the CMS negotiated-price file |
| Xospata Gilteritinib Fumarate Every route for this drug | XOSPATA is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. Label on openFDA, read 2026-11-10 | Astellas Pharma Support Solutions (program page) | not in the CMS negotiated-price file |
| Venclexta Venetoclax Every route for this drug | In combination with azacitidine, or decitabine, or low-dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy. Label on openFDA, read 2026-11-10 | myAbbVie Assist Cancer Drug Assistance (Multiple Programs) Genentech Patient Foundation | not in the CMS negotiated-price file |
| Inqovi Decitabine/Cedazuridine | In combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy. Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
| Tibsovo Ivosidenib | Newly Diagnosed Acute Myeloid Leukemia (AML) In combination with azacitidine or as monotherapy for the treatment of newly diagnosed AML in adults 75 years or older, or who have comorbidities that preclude use of ... Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
Funds for costs around Acute Myeloid Leukemia
These pay for a kind of cost, not a diagnosis. Each is shown with its own status.
Funds for costs around cancer and blood cancer in general: behavioral health (1 open of 2), caregiver support (0 open of 2), clinical trial costs (0 open of 1), home care (1 open of 1), named fund (0 open of 1), pain management (0 open of 1), testing (1 open of 1) and transportation (0 open of 1). Every one is listed, with its source, on the Cancer and blood cancer page.
Related conditions
No broader or more specific condition page for this one.
Group: Cancer and blood cancer. All conditions: the condition index. Fund board for every condition: charitable copay fund status.
What changed
First read on 2026-11-08. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.
This page as data
The same facts as JSON, each fund with its source URL and read date: acute-myeloid-leukemia.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.
Questions
Is there an open charitable copay fund for Acute Myeloid Leukemia?
As read on 2026-11-08, 2 of the 4 funds we hold for Acute Myeloid Leukemia say they are open: Acute Myeloid Leukemia from Blood Cancer United (formerly the Leukemia and Lymphoma Society) and Acute myeloid leukemia (AML) from TotalAssist (Patient Advocate Foundation copay funds). Funds open and close, so check the source page before you apply.
Which organizations run funds for Acute Myeloid Leukemia?
Blood Cancer United (formerly the Leukemia and Lymphoma Society), TotalAssist (Patient Advocate Foundation copay funds), CancerCare and HealthWell Foundation. Each fund row on this page links to the organization's own page.
Does an open fund mean I qualify?
No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.
How current is this page?
Statuses are what each fund's own page said on the date we read it (2026-11-08). We do not promise a fund is still in that state today.